Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer
Conditions
- Metastatic Malignant Neoplasm in the Brain
- Recurrent Non-Small Cell Lung Carcinoma
- Stage IV Non-Small Cell Lung Cancer AJCC v7
Interventions
- RADIATION: 3-Dimensional Conformal Radiation Therapy
- DRUG: Erlotinib Hydrochloride
- RADIATION: Stereotactic Radiosurgery
- DRUG: Temozolomide
Sponsor
National Cancer Institute (NCI)
Collaborators